Accelerating Innovation
Our track record of success inspires our pursuit of transformative medicines and cures across virology, oncology and inflammation. We’re driven to generate advances in drug discovery, out-innovate current therapeutics and help save the lives of millions of people around the world.
Over our 35-plus-year history, through our extensive early research and development program, we have consistently identified best-in-class molecules, biologics, cell therapies and combinations and brought them forward with speed and efficiency. We have helped transform global public health challenges like HIV and hepatitis C into manageable or even curable conditions and are poised to deliver revolutionary therapies in oncology and inflammation.
Our Pipeline
We have a strong and diverse pipeline, upholding our ambition, set in 2019, to deliver 10+ transformative therapies by 2030.
Explore Our PipelineLeading in HIV, Viral Hepatitis and Across Virology
Every step of our HIV research and development process is informed by the diverse experiences of people living with HIV, advocates and the communities around them. We're unwavering in our mission to continue transforming the treatment and prevention landscape through the discovery and advancement of innovative cures and therapeutics that address the needs of people affected by the epidemic across the globe.
We’re also advancing research across viral hepatitis,
SARS-CoV-2 and other viruses, including those capable of causing the next pandemic.
Progressing our
Oncology Pipeline
We’re taking a focused yet bold approach to transform oncology drug development, investing in innovative approaches that disrupt the assumptions underpinning current cancer therapies. We’re on a mission to raise the bar in oncology by accelerating treatments that provide
long-term remission and cures by killing tumors and inciting immune responses.
Leveraging our Expertise in Immunology
We’re working to develop next-generation therapies for inflammatory and fibrotic diseases that offer deep therapeutic responses and durable remissions. We’re applying our deep knowledge of the immune system to block major pathogenic pathways, eliminate pathogenic cells, tolerize the immune system and restore tissue homeostasis and functions.
Learn More About InflammationClinical Trials
We're committed to involving the communities most impacted by disease in the design and execution of our clinical trials.
Learn MoreDiscover what's next
We foster a collaborative, curious and creative culture rooted in scientific exploration. Gilead researchers are empowered to pursue extraordinary discoveries and make a transformative impact on the world.
Explore Careers